Form D · Biotechnology
BiomeSense, Inc.
Chicago, IL · CIK 0001789915
Offering snapshot reported Nov 3, 2025 · SEC filing
- Reported sold
- $7.06M Offering amount: $7.25M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 18, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 3, 2025 | Initial | $7,059,599 | No comparison | 27 | SEC filing |
| Dec 19, 2023 | Initial | $6,178,594 | No comparison | 33 | SEC filing |
| Oct 2, 2019 | Initial | $2,424,996 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-562823
Source: Form D, filed Nov 3, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Bluestein | Director |
| Orhan Ertughrul | Director |
| Vanessa Rollings Giannis | Director |
| Ashley Hartman | Director |
| Kevin Honaker | Director, Executive |
| Dylan Nichols | Director |
| Parikshit Sharma | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2242 W. Harrison St Ste 201
Chicago, IL, 60612
Chicago, IL, 60612